focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,166.00
Bid: 12,132.00
Ask: 12,136.00
Change: -6.00 (-0.05%)
Spread: 4.00 (0.033%)
Open: 12,180.00
High: 12,198.00
Low: 12,076.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: UK stocks flat ahead of US data, Fed decision

Wed, 30th Jul 2014 11:42

- Corporate earnings receive mixed market reaction- Barclays, Travis Perkins and Astra rise- Antofagasta, ITV and Compass fall- US data, Fed decision in focus later ontechMARK 2,783.73 +0.05%FTSE 100 6,803.99 -0.06%FTSE 250 15,675.20 -0.08%The FTSE 100 was trading broadly flat on Wednesday, teetering at the 6,800 level, as investors gave a mixed reaction to a flurry of corporate earnings and awaited key economic data from the States.Meanwhile, traders were still watching developments in the Ukraine crisis after US and EU leaders announced a fresh round of sanctions on Russia yesterday. Relentless fighting in Gaza and a potential debt default in Argentina were also likely to be weighing on risk appetite.London's benchmark index was 0.1% lower at 6,804 by midday as strong gains from Barclays, Travis Perkins and AstraZeneca were offset by falls from Antofagasta, ITV and Compass.After a relatively quiet start to the week on the macro calendar, things will pick up this afternoon with the focus on the closely-watched ADP employment report and second-quarter gross domestic product (GDP) estimates in the States, as well as the Federal Reserve's policy decision scheduled for this evening.The consensus forecast is for annualised US GDP growth to be 3% in the second quarter of 2014, a sharp rebound from the 2.9% contraction registered in the first quarter.As for the Fed, there will not be a press conference but the central bank's statement is likely to have a "dovish twist", according to analysts at Danske Bank, "giving an acknowledgement that the labour market is improving faster than expected". Barclays leads banks higherBarclays was up 4% as it reported a less-than-expected 12% fall in total income adjusted for insurance claims for the first half to £13.32bn, driven by reductions at its investment and African banking units. The consensus estimate had been for a drop to £13.23bn. Domestic banking peers RBS and Lloyds were also on the rise.Housebuilder Travis Perkins also impressed as it reported double-digit growth across the board in the first half, with like-for-like revenues up 10.2% and profits up 16%. The company said it expects "continued solid growth" for the rest of the year.Astrazeneca was in demand after it struck a deal with drug developer Almirall for the rights to the Spanish group's respiratory franchise. The initial consideration is $875m.Chile-focused mining group Antofagasta underwhelmed as it maintained its production guidance for 2014 after a sequential increase in output in the second quarter, while net cash costs were broadly flat. Shares of broadcaster ITV were in negative territory with the stock retreating after its recent strong run. Nevertheless, the company managed to beat expectations with its first-half results this morning with pre-tax profits up 16%.Catering and facilities management giant Compass served up a healthy third quarter of trading, improving margin across the group as revenue growth in North America remained strong while Europe and Japan improved. On the FTSE 250, retailer Pets at Home jumped after new store openings and strength in the food, accessories and services categories drove first-quarter revenues 10.4% higher.FTSE 100 - RisersBarclays (BARC) 228.10p +4.11%Travis Perkins (TPK) 1,700.00p +3.34%Royal Bank of Scotland Group (RBS) 361.60p +2.15%Capita (CPI) 1,238.00p +1.89%Carnival (CCL) 2,157.00p +1.41%Lloyds Banking Group (LLOY) 76.65p +1.35%Reckitt Benckiser Group (RB.) 5,280.00p +1.15%AstraZeneca (AZN) 4,362.00p +0.91%BAE Systems (BA.) 428.80p +0.78%BT Group (BT.A) 389.40p +0.62%FTSE 100 - FallersAntofagasta (ANTO) 834.00p -2.46%Sainsbury (J) (SBRY) 317.00p -1.95%Aberdeen Asset Management (ADN) 423.00p -1.79%ITV (ITV) 201.90p -1.51%Compass Group (CPG) 994.50p -1.34%BHP Billiton (BLT) 2,069.00p -1.29%GKN (GKN) 361.30p -1.28%3i Group (III) 388.60p -1.22%Morrison (Wm) Supermarkets (MRW) 172.40p -1.20%Ashtead Group (AHT) 920.50p -1.18%FTSE 250 - RisersPets at Home Group (PETS) 180.10p +5.94%Moneysupermarket.com Group (MONY) 189.60p +4.18%National Express Group (NEX) 265.10p +3.27%Cairn Energy (CNE) 182.80p +2.47%Diploma (DPLM) 640.00p +2.40%Bwin.party Digital Entertainment (BPTY) 87.90p +2.15%Phoenix Group Holdings (DI) (PHNX) 707.50p +2.02%PayPoint (PAY) 1,073.00p +2.00%Thomas Cook Group (TCG) 122.10p +2.00%Riverstone Energy Limited (RSE) 921.50p +1.82%FTSE 250 - FallersPace (PIC) 345.50p -4.53%International Personal Finance (IPF) 565.50p -3.50%Jupiter Fund Management (JUP) 401.70p -3.23%Just Eat (JE.) 205.10p -2.33%CSR (CSR) 538.00p -2.00%Hochschild Mining (HOC) 163.70p -1.98%Big Yellow Group (BYG) 500.50p -1.86%Infinis Energy (INFI) 235.80p -1.75%Dixons Retail (DXNS) 51.00p -1.73%Carphone Warehouse Group (CPW) 329.30p -1.70%BC
More News
14 Nov 2023 10:51

TOP NEWS: AstraZeneca Imfinzi fails to meet endpoint in cancer trial

(Alliance News) - AstraZeneca PLC on Tuesday said the Pacific-2 phase III trial for Imfinzi as an early treatment lung cancer immunotherapy treatment administered with chemoradiotherapy, did not meet its primary endpoint.

Read more
14 Nov 2023 09:22

AstraZeneca's latest lung cancer trial fails its primary endpoint

(Sharecast News) - AstraZeneca announced on Tuesday that its 'PACIFIC-2' phase three trial for Imfinzi, or durvalumab, concurrently administered with chemoradiotherapy (CRT), did not achieve its primary endpoint of progression-free survival compared to CRT alone.

Read more
13 Nov 2023 09:45

LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 Nov 2023 15:02

London close: Stocks gain as investors await Powell speech

(Sharecast News) - London's stock markets were buoyant at the close of trading on Thursday, influenced by Chinese inflation data, a substantial influx of corporate news, and a speech from the Fed chair later in the global day.

Read more
9 Nov 2023 12:06

LONDON MARKET MIDDAY: FTSE up despite higher for longer US rates fear

(Alliance News) - European equities were on the up on Thursday, despite lingering US interest rate worries and poor China data.

Read more
9 Nov 2023 11:02

Lancashire Holdings declares special dividend after strong year so far

(Alliance News) - Lancashire Holdings Ltd on Thursday said it approved a capital return of up to USD169 million, and it reported rising gross premiums written for the year-to-date.

Read more
9 Nov 2023 09:23

TOP NEWS: AstraZeneca ups guidance; inks licence deal for obesity drug

(Alliance News) - AstraZeneca PLC on Thursday announced that it signed a contract for an obesity drug as it reported a higher pretax profit in the third quarter of 2023, boosted by cancer drug conjugate Enhertu.

Read more
9 Nov 2023 08:57

LONDON MARKET OPEN: FTSE 100 kicks off day with cautious gain

(Alliance News) - London's FTSE 100 struggled for direction early Thursday, with a mixed slate of corporate updates, US interest rate worries and underwhelming China data preventing it from making more confident progress in early trade.

Read more
9 Nov 2023 07:48

LONDON BRIEFING: AstraZeneca ups outlook but S4 Capital cuts

(Alliance News) - London's FTSE 100 is set for another downbeat start to the day, with more hawkish comments from US central bankers and tepid data out of China doing little to lift the mood.

Read more
9 Nov 2023 07:18

AstraZeneca hikes guidance after strong third quarter

(Sharecast News) - AstraZeneca released its financial results for the third quarter and first nine months of 2023 on Thursday, hiking its full-year guidance on the back of a robust performance and momentum in several segments.

Read more
3 Nov 2023 17:06

AstraZeneca plans next phase of trial on kidney drug combination data

(Alliance News) - AstraZeneca PLC on Friday touted results from a Phase IIb trial, which showed that a zibotentan and dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria.

Read more
3 Nov 2023 11:34

AstraZeneca's Lokelma lets kidney disease patients maintain therapy

(Alliance News) - AstraZeneca PLC on Thursday celebrated results from an observational study, which showed that treating hyperkalaemia with the potassium binder, Lokelma, allows chronic kidney disease and heart failure patients to maintain RAASi therapy.

Read more
2 Nov 2023 15:57

UK earnings, trading statements calendar - next 7 days

Friday 3 November 
no events scheduled 
Monday 6 November 
Kingspan Group PLCTrading Statement
Kosmos Energy LtdQ3 Results
Ryanair Holdings PLCHalf Year Results
Tuesday 7 November 
Associated British Foods PLCFull Year Results
Beazley PLCQ3 Results
Direct Line Insurance Group PLCTrading Statement
dotdigital Group PLCFull Year Results
IWG PLCQ3 Results
Persimmon PLCTrading Statement
RS Group PLCHalf Year Results
Vaalco Energy IncQ3 Results
Watches of Switzerland Group PLCTrading Statement
Wednesday 8 November 
Conduit Holdings LtdQ3 Results
ITV PLCTrading Statement
JD Wetherspoon PLCQ1 Results
Marks & Spencer Group PLCHalf Year Results
MaxCyte IncQ3 Results
Secure Trust Bank PLCTrading Statement
Smiths News PLCFull Year Results
Time Out Group PLCFull Year Results
Thursday 9 November 
3i Group PLCHalf Year Results
Apax Global Alpha LtdQ3 Results
AstraZeneca PLCQ3 Results
Auto Trader Group PLCHalf Year Results
B&M European Value Retail SAHalf Year Results
Domino's Pizza Group PLCTrading Statement
Endeavour Mining PLCQ3 Results
Flutter Entertainment PLCTrading Statement
IMI PLCTrading Statement
Indivior PLCQ3 Results
John Wood Group PLCTrading Statement
Lancashire Holdings LtdTrading Statement
National Grid PLCHalf Year Results
Regional REIT LtdTrading Statement
Renewi PLCHalf Year Results
S4 Capital PLCTrading Statement
Tate & Lyle PLCHalf Year Results
Taylor Wimpey PLCTrading Statement
TBC Bank Group PLCQ3 Results
TheWorks.co.uk PLCTrading Statement
Trakm8 Holdings PLCHalf Year Results
Urban Logistics REIT PLCHalf Year Results
Vistry Group PLCTrading Statement
WH Smith PLCFull Year Results
Wincanton PLCHalf Year Results
Wizz Air Holdings PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
1 Nov 2023 08:59

AstraZeneca launches collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Wednesday announced a new collaboration and investment agreement with clinical-stage biotechnology company Cellectis.

Read more
1 Nov 2023 07:33

AstraZeneca invests $220m in French gene-editing group Cellectis

(Sharecast News) - AstraZeneca is to invest in French biopharma group Cellectis to use its gene-editing technologies to develop next-gen therapeutics in areas like oncology, immunology and rare diseases.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.